NCT06902077Recruiting
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
Carb Control: Low-Carbohydrate Dietary Intervention for Pediatric Patients With Type 2 Diabetes
Source: ClinicalTrials.gov · Last updated 8 Dec 2025
Brief summary (registry, in English)
The purpose of this project is to test the effect of a low carb diet compared to standard carb diet among adolescents with T2D over a 24-week period.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 7 Mar 2025
- Start date
- 25 Nov 2025
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Type 2 diabetes
- NCT number
- NCT06902077
What you commit to
- Study type: Interventional
- Planned participants: 40
- From 25 Nov 2025 to the primary completion date, 31 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Renal impairment measured as creatinine \> 1 mg/dL
- Hepatic dysfunction measured as AST and ALT \>100 IU/ml
Other
- Current insulin treatment
Who the study is looking for
- Age 12-18
- Diabetes diagnosis \>3 months to ensure stable baseline glycemic control
- HbA1C between 6.5- 8.5%
- BMI \>85th percentile
- Negative pancreatic autoantibodies
- Stable dose of anti-diabetic drugs GLP-1, metformin, SGLT-2 inhibitors, for 3 months
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham, Children's of Alabama Coordinator of this site? Confirm its status | Birmingham | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.